Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Judith P. Willner is active.

Publication


Featured researches published by Judith P. Willner.


Neurology | 2005

Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome

Volney L. Sheen; An Jansen; Ming-Hui Chen; Elena Parrini; Timothy R. Morgan; R. Ravenscroft; Vijay S. Ganesh; T. Underwood; James S. Wiley; Richard J. Leventer; R. R. Vaid; D. E. Ruiz; G. M. Hutchins; J. Menasha; Judith P. Willner; Y. Geng; Karen W. Gripp; L. Nicholson; Elizabeth Berry-Kravis; Adria Bodell; Kira Apse; Robert Sean Hill; François Dubeau; F. Andermann; James Barkovich; Eva Andermann; Yin Yao Shugart; Pierre Thomas; Maurizio Viri; Pierangelo Veggiotti

Objective: To define the clinical, radiologic, and genetic features of periventricular heterotopia (PH) with Ehlers-Danlos syndrome (EDS). Methods: Exonic sequencing and single stranded conformational polymorphism (SSCP) analysis was performed on affected individuals. Linkage analysis using microsatellite markers on the X-chromosome was performed on a single pedigree. Western blotting evaluated for loss of filamin A (FLNA) protein and Southern blotting assessed for any potential chromosome rearrangement in this region. Results: The authors report two familial cases and nine additional sporadic cases of the EDS-variant form of PH, which is characterized by nodular brain heterotopia, joint hypermobility, and development of aortic dilatation in early adulthood. MRI typically demonstrated bilateral nodular PH, indistinguishable from PH due to FLNA mutations. Exonic sequencing or SSCP analyses of FLNA revealed a 2762 delG single base pair deletion in one affected female. Another affected female harbored a C116 single point mutation, resulting in an A39G change. A third affected female had a 4147 delG single base pair deletion. One pedigree with no detectable exonic mutation demonstrated positive linkage to the FLNA locus Xq28, an affected individual in this family also had no detectable FLNA protein, but no chromosomal rearrangement was detected. Conclusion: These results suggest that the Ehlers-Danlos variant of periventricular heterotopia (PH), in part, represents an overlapping syndrome with X-linked dominant PH due to filamin A mutations.


American Journal of Medical Genetics | 1997

Paternal uniparental disomy for chromosome 14 : a case report and review

Philip D. Cotter; Sara Kaffe; Leslie D. McCurdy; Meenakshi Jhaveri; Judith P. Willner; Kurt Hirschhorn

Uniparental disomy (UPD) for several chromosomes has been associated with disease phenotypes. Maternal UPD for chromosome 14 has been described and has a characteristic abnormal phenotype. Paternal UPD14 is rare and only three previous cases have been reported. We describe a new case of paternal UPD for chromosome 14 in an infant with a 45,XX,der(13q;14q) karyotype, which was confirmed by molecular analysis. The proposita had findings similar to those of the previous cases of patUPD14 and we conclude that there is a characteristic patUPD14 syndrome most likely due to imprinting effects. Couples with Robertsonian translocations involving chromosome 14 should be counseled as to the possibility of UPD14 and the option of prenatal diagnosis when indicated.


Molecular Autism | 2013

Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency

Latha Soorya; Alexander Kolevzon; Jessica Zweifach; Teresa Lim; Yuriy Dobry; Lily Schwartz; Yitzchak Frank; A. Ting Wang; Guiqing Cai; Elena Parkhomenko; Danielle Halpern; David Grodberg; Benjamin Angarita; Judith P. Willner; Amy Yang; Roberto Canitano; William F. Chaplin; Catalina Betancur; Joseph D. Buxbaum

Background22q13 deletion syndrome, also known as Phelan-McDermid syndrome, is a neurodevelopmental disorder characterized by intellectual disability, hypotonia, delayed or absent speech, and autistic features. SHANK3 has been identified as the critical gene in the neurological and behavioral aspects of this syndrome. The phenotype of SHANK3 deficiency has been described primarily from case studies, with limited evaluation of behavioral and cognitive deficits. The present study used a prospective design and inter-disciplinary clinical evaluations to assess patients with SHANK3 deficiency, with the goal of providing a comprehensive picture of the medical and behavioral profile of the syndrome.MethodsA serially ascertained sample of patients with SHANK3 deficiency (n = 32) was evaluated by a team of child psychiatrists, neurologists, clinical geneticists, molecular geneticists and psychologists. Patients were evaluated for autism spectrum disorder using the Autism Diagnostic Interview-Revised and the Autism Diagnostic Observation Schedule-G.ResultsThirty participants with 22q13.3 deletions ranging in size from 101 kb to 8.45 Mb and two participants with de novo SHANK3 mutations were included. The sample was characterized by high rates of autism spectrum disorder: 27 (84%) met criteria for autism spectrum disorder and 24 (75%) for autistic disorder. Most patients (77%) exhibited severe to profound intellectual disability and only five (19%) used some words spontaneously to communicate. Dysmorphic features, hypotonia, gait disturbance, recurring upper respiratory tract infections, gastroesophageal reflux and seizures were also common. Analysis of genotype-phenotype correlations indicated that larger deletions were associated with increased levels of dysmorphic features, medical comorbidities and social communication impairments related to autism. Analyses of individuals with small deletions or point mutations identified features related to SHANK3 haploinsufficiency, including ASD, seizures and abnormal EEG, hypotonia, sleep disturbances, abnormal brain MRI, gastroesophageal reflux, and certain dysmorphic features.ConclusionsThis study supports findings from previous research on the severity of intellectual, motor, and speech impairments seen in SHANK3 deficiency, and highlights the prominence of autism spectrum disorder in the syndrome. Limitations of existing evaluation tools are discussed, along with the need for natural history studies to inform clinical monitoring and treatment development in SHANK3 deficiency.


Neurology | 1981

Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia Clinical, morphologic, and biochemical studies of nine cases

Judith P. Willner; Gregory A. Grabowski; Ronald E. Gordon; Adam N. Bender; Robert J. Desnick

A progressive spinocerebellar degenerative disorder was characterized in nine patients, aged 11 to 37 years, from four unrelated Ashkenazi Jewish families; affected individuals had markedly deficient β-hexosaminidase A activity. Symptoms included early onset of cerebellar signs (tremor, incoordination, and dysarthia) and, with maturity, the development of upper and lower motor neuron disorders, marked dysarthria, and ataxia. Three older patients, aged 26, 32, and 37 years, had dementia or recurrent psychotic episodes. Membrane-bound lamellar cytoplasmic inclusions, consistent with lysosomal ganglioside accumulation, were observed in rectal ganglia. The activity of β-hexosaminidase A was markedly deficient in all sources analyzed. Parents had activities consistent with heterozygosity, confirming autosomal-recessive transmission of the β-hexosaminidase A-deficient gene and the adult variant disorder. Residual β-hexosaminidase A activity, partially purified by anion-exchange chromatography from cultured skin fibroblasts of the affected individuals, was heat-labile and co-electrophoresed with normal β-hexosaminidase A. These findings suggest that these patients were allelic for a new β-hexosaminidase A mutation and may represent a genetic compound of this allele and the allele causing Tay-Sachs disease.


American Journal of Human Genetics | 1998

Paternal Uniparental Disomy for Chromosome 1 Revealed by Molecular Analysis of a Patient with Pycnodysostosis

Bruce D. Gelb; Judith P. Willner; Teresa M. Dunn; Nataline B. Kardon; Alain Verloes; Jacques Poncin; Robert J. Desnick

Molecular analysis of a patient affected by the autosomal recessive skeletal dysplasia, pycnodysostosis (cathepsin K deficiency; MIM 265800), revealed homozygosity for a novel missense mutation (A277V). Since the A277V mutation was carried by the patients father but not by his mother, who had two normal cathepsin K alleles, paternal uniparental disomy was suspected. Karyotyping of the patient and of both parents was normal, and high-resolution cytogenetic analyses of chromosome 1, to which cathepsin K is mapped, revealed no abnormalities. Evaluation of polymorphic DNA markers spanning chromosome 1 demonstrated that the patient had inherited two paternal chromosome 1 homologues, whereas alleles for markers from other chromosomes were inherited in a Mendelian fashion. The patient was homoallelic for informative markers mapping near the chromosome 1 centromere, but he was heteroallelic for markers near both telomeres, establishing that the paternal uniparental disomy with partial isodisomy was caused by a meiosis II nondisjunction event. Phenotypically, the patient had normal birth height and weight, had normal psychomotor development at age 7 years, and had only the usual features of pycnodysostosis. This patient represents the first case of paternal uniparental disomy of chromosome 1 and provides conclusive evidence that paternally derived genes on human chromosome 1 are not imprinted.


The Journal of Pediatrics | 1978

Spastic quadriparesis due to C1–C2 subluxation in hurler syndrome

Charles B. Brill; Judith S. Rose; Lynn Godmilow; Susan L. Sklower; Judith P. Willner; Kurt Hirschhorn

6. Ando T, and Nyhan WL: Propionic acidemia and the ketotic hyperglycinemia syndrome, in Nyhan WL, editor: Heritable DiSorders of amino acid metabolism, New York, 1974, John Wiley & Sons, inc. 7. Scriver CR, and Rosenberg LE: Amino acid metabolism and its disorders, Philadelphia, 1973, WB Saunders Company. 8. Bray PF, Herbst W, Johnson DG, Book LS, Ziter FA, and Condon VR: Childhood gastro-esophageal reflux mimicking neuropsychiatric disease, Arch Neurol 33A:388, 1976.


Journal of The American Academy of Dermatology | 2004

Infantile systemic hyalinosis.

Helen T. Shin; Amy S. Paller; George Hoganson; Judith P. Willner; Mary Wu Chang; Seth J. Orlow

Infantile systemic hyaloinosis is a rare, progressive, and fatal disease that is inherited in an autosomal recessive fashion. We describe 2 patients in whom thickened skin; small nodules of the perianal region, face, and neck; joint contractures; growth failure; diarrhea; and frequent infections developed within the first few weeks of life. Both patients died before 2 years of age.


Brain Research | 2011

Analysis of a purported SHANK3 mutation in a boy with autism: clinical impact of rare variant research in neurodevelopmental disabilities.

Alexander Kolevzon; Guiqing Cai; Latha Soorya; Nagahide Takahashi; David Grodberg; Yuji Kajiwara; Judith P. Willner; Ana Tryfon; Joseph D. Buxbaum

There is strong evidence for rare, highly penetrant genetic variants playing an etiological role in multiple neurodevelopmental disabilities, including autism spectrum disorders. The rate of discovery of such rare variants is increasing with the advent of larger sample collections, chromosome microarray analyses, and high-throughput sequencing. As the variants that are being discovered can be highly penetrant, they lead immediately to model systems with construct validity, critical for understanding the underlying neurobiology of these conditions, which in turn can provide leads for novel therapeutic targets. Moreover, these discoveries can benefit families with information about recurrence risk, resolve concerns about etiology, provide information about associated medical issues, and engender directed advocacy for specific genetic conditions. For these reasons, diagnostic laboratories are taking advantage of research data as they are produced. In the current report, we present our molecular analysis of a child with a purported disruptive mutation in SHANK3 identified by a commercial genetic testing laboratory and we provide evidence that this was not an etiological variant. The variant was a 1-bp insertion in exon 11 of the RefSeq gene, which we then determined was inherited from a healthy mother and found in ~1% of controls. Since the variant would be predicted to disrupt the reference gene, and the penetrance of SHANK3 mutations is very high, we did follow up molecular and bioinformatic analyses and concluded that the presumptive exon containing the variant is not likely to be present in most or all SHANK3 transcripts. The results highlight difficulties that can arise with rapid translation of research findings to clinical practice. Researchers are in a unique position to generate resources with collated and curated information that can inform research, genetic testing, clinicians, and families about the best practices as pertains to rare genetic variants in neurodevelopmental disabilities. Of immediate importance would be a well-curated database of gene variation identified in large numbers of typically developing individuals and in individuals affected with neurodevelopmental disabilities. Such a database would reduce false-positive results in clinical settings, would be helpful in structure-function analyses, and would direct translational research to pathways most likely to benefit families.


Clinical Genetics | 2008

Mosaicism for a small supernumerary ring X chromosome in a dysmorphic, growth-retarded male: mos47,XXY/48,XXY, + r(X)

Susan R. Manea; Irina F. Gershin; Arvind Babu; Judith P. Willner; Robert J. Desnick; Philip D. Cotter

Supernumerary ring X [r(X)] chromosomes are often found in patients with Turner syndrome. The phenotypic effects of the r(X) chromosome are variable, and largely depend on the presence or absence of the X inactivation (XIST) locus. Ring(X) chromosomes in males are rare and have been previously reported in only four cases, with 47,XY, + r(X) or mos47,XY, + r(X)/46,XY karyotypes. These patients all had developmental delay and dysmorphic features. We describe a 2.5‐year‐old male patient with facial dysmorphia, growth retardation, microcephaly, global developmental delay, and microphallus. Cytogenetic analysis from peripheral blood lymphocytes and fibroblasts identified mosaicism for two cell lines: mos48,XXY, + r(?X)/47,XXY. Fluorescence in situ hybridization (FISH) with an X chromosome paint showed the ring chromosome to be X chromosome derived. This is the first case of an r(X) chromosome described in a 47,XXY patient. FISH analysis of the r(X) chromosome with an XIST probe showed that the XIST locus was absent. Functional disomy of genes in the r(X) chromosome most likely accounts for the abnormal phenotype in the proband.


American Journal of Medical Genetics | 2000

Prenatal diagnosis of trisomy 4 mosaicism

Ann-Leslie Zaslav; Donna Blumenthal; Judith P. Willner; Guy Pierno; Jesse Jacob; Joyce E. Fox

Trisomy 4 mosaicism is rare. To our knowledge only two cases of prenatally diagnosed trisomy 4 mosaicism have been reported. One case resulted in a normal liveborn male, the other resulted in an abnormal liveborn female. The karyotype of our case at the time of amniocentesis was 47,XY,+4[3]/ 46,XY[33] and resulted in a normal liveborn male. FISH analysis using an alpha satellite chromosome 4 probe was performed to confirm the cytogenetic findings. Follow-up chromosome analysis of cord blood, peripheral blood, foreskin, and umbilical cord fibroblasts showed a normal 46,XY male karyotype in all cells. FISH analysis of cord blood, umbilical cord fibroblasts, and amniotic fluid cells demonstrated two signals in 246 nuclei (i.e., 46,XY) and three signals in six nuclei (i.e., 47,XY,+4). Here we describe the present case of trisomy 4 mosaicism, the literature is reviewed, and the significance of this finding is discussed.

Collaboration


Dive into the Judith P. Willner's collaboration.

Top Co-Authors

Avatar

Robert J. Desnick

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Philip D. Cotter

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Arvind Babu

Beth Israel Medical Center

View shared research outputs
Top Co-Authors

Avatar

Kurt Hirschhorn

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Bruce D. Gelb

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

Irina F. Gershin

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

June A. Peters

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Sharon A. Savage

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Alexander Kolevzon

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge